AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2026
Mar 3, 2026
31949_dirs_2026-03-03_a72f388c-1e8d-47a2-9013-4caea519bcdc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2026-02-28
Reporting Person: Ben Arye Barak (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-28 | Ordinary Shares | A | 17755.00 | $0.00 | Acquired | 192328.00 | Direct |
Footnotes
F1: Represents vesting of performance-based restricted stock units.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3